Moderna-backed Metagenomi cuts US IPO valuation target to $563 million
Genetic medicines company Metagenomi Technologies said on Thursday it is aiming for a valuation of $563 million in its US ...
Tag: Modernabacked
Genetic medicines company Metagenomi Technologies said on Thursday it is aiming for a valuation of $563 million in its US ...